Pulmonary Research Studies (COPD and Idiopathic Pulmonary Fibrosis)

ASCENT - Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD LAS-MD-45

 

BIPI 1199.177 - Multi-center open-label expanded access program of oral nintedanib 150 mg twice daily in patients with idiopathic pulmonary fibrosis.

 

PIPF-031 - A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary

Fibrosis Access to Pirfenidone

 
 
 

To obtain information about a clinical trial being conducted at Medical Consultants, please contact us at the following:

 

                        ResearchStudy@medicalconsultantspc.com

 

                        Or call 765-281-2000

 

  To learn more information on a specific research trial, go to www.clinicaltrials.gov
Pre-Register
For Referring Physicians
Find a Doctor
Online Billing
View Medical Records
Surgery Center Portal

Call for Info

1-877-421-5200



Privacy Policy  |   Legal Notice  |   HIPAA Notice